Communication
Organic & Biomolecular Chemistry
further testing is needed to confirm this. Overall, the data indi-
cate that consecutive amides are well tolerated in biological
systems.
5 J. Harborth, S. M. Elbashir, K. Vandenburgh, H. Manninga,
S. A. Scaringe, K. Weber and T. Tuschl, Antisense Nucleic
Acid Drug Dev., 2003, 13, 83–105.
For RNA2 we synthesized and studied both 5′-phosphoryl-
ated (5′-P) and non-phosphorylated (5′-OH) variants (Fig. 3A).
In RNAi the guide strand must be 5′-phosphorylated before
loading in Argonaute 2, the key protein of the RNA Induced
Silencing Complex (RISC). Consequently, phosphorylation of
the passenger strand may decrease the activity by enhancing
the loading of the passenger strand instead of the guide
strand. Consistent with this notion, the non-phosphorylated
Control and RNA2 were more active than the respective phos-
phorylated siRNAs (Fig. 3A). Interestingly, phosphorylation
6 M. Amarzguioui, T. Holen, E. Babaie and H. Prydz, Nucleic
Acids Res., 2003, 31, 589–595.
7 S. M. Freier and K. H. Altmann, Nucleic Acids Res., 1997, 25,
4429–4443.
8 A. De Mesmaeker, A. Waldner, J. Lebreton, P. Hoffmann,
V. Fritsch, R. M. Wolf and S. M. Freier, Angew. Chem., Int.
Ed. Engl., 1994, 33, 226–229.
9 A. De Mesmaeker, C. Lesueur, M. O. Bevierre, A. Waldner,
V. Fritsch and R. M. Wolf, Angew. Chem., Int. Ed. Engl.,
1996, 35, 2790–2794.
had a smaller effect on the activity of amide-modified siRNAs 10 M. J. J. Blommers, U. Pieles and A. de Mesmaeker, Nucleic
than on the unmodified controls, indicating that the amide
modifications may participate in RISC loading.
Most of the studies on backbone-modified DNA and RNA
have been done on isolated modifications imbedded in un-
modified nucleic acids.7 However, optimization of the biological
Acids Res., 1994, 22, 4187–4194.
11 M. Nina, R. Fonne-Pfister, R. Beaudegnies, H. Chekatt,
P. M. J. Jung, F. Murphy-Kessabi, A. De Mesmaeker
and S. Wendeborn, J. Am. Chem. Soc., 2005, 127, 6027–
6038.
properties of siRNAs is likely to require multiple and consecu- 12 P. Von Matt, A. De Mesmaeker, U. Pieles, W. Zurcher
tive modifications that are more difficult to accommodate
and K. H. Altmann, Tetrahedron Lett., 1999, 40, 2899–
because even small conformational changes may multiply and
2902.
significantly distort an RNA duplex. Herein, we show for the 13 (a) M. J. Robins, S. Sarker, M. Xie, W. Zhang and
first time that three consecutive amide linkages are well
accommodated in the middle of a short RNA duplex. Although
the amides cause some loss of thermal stability, the overall
RNA structure is only minimally altered. Consistent with small
structural changes, three consecutive amide modifications in
M. A. Peterson, Tetrahedron Lett., 1996, 37, 3921–3924;
(b) M. J. Robins, R. Zou, Z. Guo and S. F. Wnuk, J. Org.
Chem., 1996, 61, 9207–9212; (c) M. A. Peterson,
B. L. Nilsson, S. Sarker, B. Doboszewski, W. Zhang and
M. J. Robins, J. Org. Chem., 1999, 64, 8183–8192.
the passenger strand cause little change in siRNA activity. Our 14 M. J. Robins, B. Doboszewski, B. L. Nilsson and
results suggest that amides are excellent mimics of the phos-
phate backbone in RNA and may have the potential to opti-
mize biological properties of siRNAs.
M. A. Peterson, Nucleosides, Nucleotides Nucleic Acids, 2000,
19, 69–86.
15 (a) E. Rozners and R. Strömberg, Nucleosides Nucleotides,
1997, 16, 967–970; (b) E. Rozners, D. Katkevica, E. Bizdena
and R. Strömberg, J. Am. Chem. Soc., 2003, 125, 12125–
12136.
Acknowledgements
16 C. Selvam, S. Thomas, J. Abbott, S. D. Kennedy and
E. Rozners, Angew. Chem., Int. Ed., 2011, 50, 2068–2070.
17 (a) R. Iwase, H. Miyao, T. Toyama and K. Nishimori, Nucleic
Acids Symp. Ser., 2006, 175–176; (b) R. Iwase, T. Toyama
and K. Nishimori, Nucleosides, Nucleotides Nucleic Acids,
2007, 26, 1451–1454.
We thank NIH (R01 GM071461) for financial support of this
research. The Regional NMR Facility (600 MHz instrument) at
Binghamton University is supported by NSF (CHE-0922815).
We thank Daniel Mutisya for synthesis of 3b.
18 P. Tanui, M. Kullberg, N. Song, Y. Chivate and E. Rozners,
Tetrahedron, 2010, 66, 4961–4964.
Notes and references
1 J. K. Watts and D. R. Corey, J. Pathol., 2012, 226, 365–379.
2 G. F. Deleavey and M. J. Damha, Chem. Biol., 2012, 19, 937–
954.
19 (a) E. Rozners and Y. Liu, Org. Lett., 2003, 5, 181–184;
(b) E. Rozners and Y. Liu, J. Org. Chem., 2005, 70, 9841–
9848.
3 C. F. Bennett and E. E. Swayze, Annu. Rev. Pharmacol. 20 (a) E. Rozners and J. Moulder, Nucleic Acids Res., 2004, 32,
Toxicol., 2010, 50, 259–293.
4 D. A. Braasch, S. Jensen, Y. Liu, K. Kaur, K. Arar,
248–254; (b) E. Rozners, Curr. Protoc. Nucleic Acid Chem.,
2010, 43, 7.14.11–17.14.13.
M. A. White and D. R. Corey, Biochemistry, 2003, 42, 7967– 21 W. Gong and J.-P. Desaulniers, Bioorg. Med. Chem. Lett.,
7975.
2012, 22, 6934–6937.
1210 | Org. Biomol. Chem., 2014, 12, 1207–1210
This journal is © The Royal Society of Chemistry 2014